T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection

被引:40
|
作者
Shimizu, Yukihiro [1 ]
机构
[1] Takaoka City Hosp, Gastroenterol Unit, Takaoka, Toyama 9338550, Japan
关键词
T cells; Immunopathogenesis; Immunotherapy; Hepatitis B virus infection; COLONY-STIMULATING FACTOR; CHRONIC HBV INFECTION; TRANSGENIC MICE; COMBINATION THERAPY; THYMOSIN ALPHA-1; VIRAL-HEPATITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; LAMIVUDINE TREATMENT; ANTIVIRAL THERAPY;
D O I
10.3748/wjg.v18.i20.2443
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B is caused by the host immune response and T cells play a major role in the immunopathogenesis. More importantly, T cells not only destroy hepatocytes infected by hepatitis B virus (HBV), but also control HBV replication or eradicate HBV in a noncytolytic manner. Therefore, analysis of T cell immune response during acute and chronic HBV infection is important to develop a strategy for successful viral control, which could lead to immunotherapy for terminating persistent HBV infection. There have been many attempts at immunotherapy for chronic HBV infection, and some have shown promising results. High viral load has been shown to suppress antiviral immune responses and immunoinhibitory signals have been recently elucidated, therefore, viral suppression by nucleos(t)ide analogs, stimulation of antiviral immune response, and suppression of the immunoinhibitory signals must be combined to achieve desirable antiviral effects. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2443 / 2451
页数:9
相关论文
共 50 条
  • [1] T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection
    Yukihiro Shimizu
    World Journal of Gastroenterology, 2012, (20) : 2443 - 2451
  • [2] Immunopathogenesis of hepatitis B persistent infection: Implications for immunotherapeutic strategies
    Kondo Y.
    Ueno Y.
    Shimosegawa T.
    Clinical Journal of Gastroenterology, 2009, 2 (2) : 71 - 79
  • [3] Immunopathogenesis and therapeutic vaccine strategies for chronic hepatitis B virus infection
    Michel, Marie-Louise
    VIROLOGIE, 2014, 18 (01) : 25 - 33
  • [4] Epidemiology and immunopathogenesis of chronic hepatitis B virus infection
    Edward Doo
    Current Hepatitis Reports, 2003, 2 (2) : 79 - 81
  • [5] Immunopathogenesis of hepatitis B virus infection
    Chang, J. Judy
    Lewin, Sharon R.
    IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (01): : 16 - 23
  • [6] Immunotherapeutic interventions in chronic hepatitis B virus infection: A review
    Wang, Li
    Zou, Zhi Qiang
    Liu, Cheng Xia
    Liu, Xiang Zhong
    JOURNAL OF IMMUNOLOGICAL METHODS, 2014, 407 : 1 - 8
  • [7] Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection
    Zhang, Zheng
    Zhang, Ji-Yuan
    Wang, Li-Feng
    Wang, Fu-Sheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 223 - 230
  • [8] Immunopathogenesis of chronic hepatitis C virus infection
    Li, DY
    Schwarz, KB
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 (03): : 260 - 267
  • [9] The CD8+T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review
    Allahmoradi, Esmaeil
    Mohammadi, Ramtin
    Zarandi, Peyman Kheirandish
    Alavian, Seyed Moayed
    Heiat, Mohammad
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (06) : 671 - 688
  • [10] T cell epitope mapping of hepatitis B virus in chronic infection
    Viuff, Marie
    Tuefferd, Marianne
    Heeke, Christina
    Munk, Kamilla Kjaergaard
    Kadivar, Mohammad
    Lauer, Georg
    Bollekens, Jacques
    Hadrup, Sine Reker
    JOURNAL OF HEPATOLOGY, 2022, 77 : S271 - S272